Elicio Therapeutics, Inc.

US$1.51As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ELTXHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (42.16%)
Div yield —
ROE (315.32%)
Biotechnology
Beta (5Y) 2.00
PE TTM —
TSR TTM (83.75%)
Mkt cap US$39.69M
ROIC (98.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.61
6.61%
(30.49%)
Hold 10|6|4|12|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
25.54%
18.83%
5.31%
17.99%
Revenue$M
1.845
1.915
1.892
1.844
(0.75%)
5.22%
3.02%
(2.38%)
Peers (US$39.69M)
Cap (US$)
PE
40.84M
—
Capital
TTM
5Y
10Y
Leveragex
1.512
(1.854)
(1.653)
EBIT/Intx
0.349
0.542
0.390
Own earn%
22.92
(163.05)
(122.71)
Sh yield%
21.09
37.41
40.15
Owners
Insiders/Inst%
12.54
79.14
Short interest%
1.70
SBC / revenue%
1.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–2
$1 testx
—
Incr. ROIC%
11